Scientific article
English

Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis

Published in

Circulation. Heart failure, vol. 7, no. 3, p. 409-417

Publication date

2014

Abstract

Fibroblast growth factor-23 (FGF-23) is a phosphate regulatory hormone that directly stimulates left ventricular hypertrophy in experimental models. The role of FGF-23 in cardiovascular disease development in the general population is unclear. We tested associations of FGF-23 with major subclinical and clinical cardiovascular disease outcomes in a large prospective cohort.

Keywords

  • Aged
  • Aged, 80 and over
  • Atherosclerosis/blood/epidemiology/ethnology
  • Biomarkers/blood
  • Calcium/metabolism
  • Cardiovascular Diseases/blood/epidemiology/ethnology
  • Carotid Intima-Media Thickness
  • Cohort Studies
  • Coronary Vessels/metabolism
  • Female
  • Fibroblast Growth Factors/blood
  • Heart Ventricles/pathology
  • Humans
  • Incidence
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Prospective Studies
  • Risk Factors
  • United States

Citation (ISO format)

KESTENBAUM, Bryan et al. Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis. In: Circulation. Heart failure, 2014, vol. 7, n° 3, p. 409–417. doi: 10.1161/CIRCHEARTFAILURE.113.000952

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1941-3289
464views
0downloads

Technical informations

Creation

30/10/2016 13:28:00

First validation

30/10/2016 13:28:00

Update

27/01/2025 15:25:50

Status update

27/01/2025 15:25:50

Last indexation

27/01/2025 15:36:47
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated